Lushi Avner

Lushi Avner is listed in filings as Director at Silexion Therapeutics Ltd.. This profile follows SEC Form 4 activity through Feb 23, 2026, including 4 public disclosures. Recent filings connect the profile to Silexion Therapeutics Ltd. (SLXN). The current snapshot covers public activity from Dec 31, 2025 to Feb 23, 2026. Reported amounts are shown as $17.6K to $35.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.